Nano PharmaSolutions, Inc. is developing a proprietary drug delivery technology that generates nanoparticles by vaporizing the solid API and then uniformly depositing the solidified molecules of the drug onto the surface of FDA-approved, free-flowing carrier particles. We designed a prototype phase transformer and currently undergoing proof of concept. The resulting nanodrug pharmaceutical intermediates can be further processed into any existing dosage form which will vastly increase the size of the generic drug market. Our technology serves generic drug industry by improving bioavailability, thereby enhancing the generic drug market size. We also offer nanoformulation development service for emerging pharma Co for poorly soluble drugs in clinical stage.
Our nanodrugs can be made into tablets, capsules, drops, or inhalers. We serve generic drug industry to improve bioavailability. We also offer formulation service for emerging pharma for poorly soluble drugs in clinical stage.
We develop a proprietary drug delivery technology using drug nanoparticles, which is made into oral solid dosage forms, drops, or inhalers. We also offer nanoformulation development service for emerging pharma Co for poorly soluble drugs.